440 related articles for article (PubMed ID: 34428558)
1. Structural principles of insulin formulation and analog design: A century of innovation.
Jarosinski MA; Dhayalan B; Chen YS; Chatterjee D; Varas N; Weiss MA
Mol Metab; 2021 Oct; 52():101325. PubMed ID: 34428558
[TBL] [Abstract][Full Text] [Related]
2. Evolution of insulin development: focus on key parameters.
Tibaldi JM
Adv Ther; 2012 Jul; 29(7):590-619. PubMed ID: 22843207
[TBL] [Abstract][Full Text] [Related]
3. Design of non-standard insulin analogs for the treatment of diabetes mellitus.
Pandyarajan V; Weiss MA
Curr Diab Rep; 2012 Dec; 12(6):697-704. PubMed ID: 22983891
[TBL] [Abstract][Full Text] [Related]
4. New Horizons: Next-Generation Insulin Analogues: Structural Principles and Clinical Goals.
Jarosinski MA; Chen YS; Varas N; Dhayalan B; Chatterjee D; Weiss MA
J Clin Endocrinol Metab; 2022 Mar; 107(4):909-928. PubMed ID: 34850005
[TBL] [Abstract][Full Text] [Related]
5. The development of new basal insulins: is there any clinical advantage with their use in type 2 diabetes?
Maiorino MI; Petrizzo M; Capuano A; Giugliano D; Esposito K
Expert Opin Biol Ther; 2014 Jun; 14(6):799-808. PubMed ID: 24673155
[TBL] [Abstract][Full Text] [Related]
6. Insulin preparations with prolonged effect.
Owens DR
Diabetes Technol Ther; 2011 Jun; 13 Suppl 1():S5-14. PubMed ID: 21668337
[TBL] [Abstract][Full Text] [Related]
7. Biosynthetic Human Insulin and Insulin Analogs.
Rodbard HW; Rodbard D
Am J Ther; 2020; 27(1):e42-e51. PubMed ID: 31876563
[TBL] [Abstract][Full Text] [Related]
8. Understanding how pharmacokinetic and pharmacodynamic differences of basal analog insulins influence clinical practice.
Goldman J; Kapitza C; Pettus J; Heise T
Curr Med Res Opin; 2017 Oct; 33(10):1821-1831. PubMed ID: 28537449
[TBL] [Abstract][Full Text] [Related]
9. The evolution of insulin therapy in diabetes mellitus.
Heile M; Schneider D
J Fam Pract; 2012 May; 61(5 Suppl):S6-12. PubMed ID: 22577636
[No Abstract] [Full Text] [Related]
10. A review of a family of ultra-rapid-acting insulins: formulation development.
Krasner A; Pohl R; Simms P; Pichotta P; Hauser R; De Souza E
J Diabetes Sci Technol; 2012 Jul; 6(4):786-96. PubMed ID: 22920803
[TBL] [Abstract][Full Text] [Related]
11. Closer to ideal insulin action: ultra fast acting insulins.
Cengiz E
Panminerva Med; 2013 Sep; 55(3):269-75. PubMed ID: 24088800
[TBL] [Abstract][Full Text] [Related]
12. One-hundred year evolution of prandial insulin preparations: From animal pancreas extracts to rapid-acting analogs.
Bolli GB; Porcellati F; Lucidi P; Fanelli CG; Owens DR
Metabolism; 2022 Jan; 126():154935. PubMed ID: 34762931
[TBL] [Abstract][Full Text] [Related]
13. Understanding concentrated insulins: a systematic review of randomized controlled trials.
Ovalle F; Segal AR; Anderson JE; Cohen MR; Morwick TM; Jackson JA
Curr Med Res Opin; 2018 Jun; 34(6):1029-1043. PubMed ID: 29166786
[TBL] [Abstract][Full Text] [Related]
14. Gla-100 Development: a Story of 'Serendipitous' Disruptive Innovation.
Badgandi M; Negalur V; Reddy PS; Venkataraman S; Kota S; Barman KK; Jayaprassad V; Pasha MY; Sruthisri P; Mohan V
J Assoc Physicians India; 2020 Dec; 68(12[Special]):13-17. PubMed ID: 33247658
[TBL] [Abstract][Full Text] [Related]
15. [A 50-year history of new drugs in Japan-the development and progress of anti-diabetic drugs and the epidemiological aspects of diabetes mellitus].
Ozawa H; Murai Y; Ozawa T
Yakushigaku Zasshi; 2003; 38(1):11-27. PubMed ID: 14570054
[TBL] [Abstract][Full Text] [Related]
16. Insulin analogs--is there a compelling case to use them? No!
Davidson MB
Diabetes Care; 2014 Jun; 37(6):1771-4. PubMed ID: 24855160
[TBL] [Abstract][Full Text] [Related]
17. The Evolution of Insulin and How it Informs Therapy and Treatment Choices.
Hirsch IB; Juneja R; Beals JM; Antalis CJ; Wright EE
Endocr Rev; 2020 Oct; 41(5):733-55. PubMed ID: 32396624
[TBL] [Abstract][Full Text] [Related]
18. Addressing Unmet Needs With Injectable Medications in Type 2 Diabetes Treatment: Basal insulins.
Mora PF
J Fam Pract; 2017 Oct; 66(10 Suppl):S7-S11. PubMed ID: 28991931
[TBL] [Abstract][Full Text] [Related]
19. Insulin analogs: Glimpse on contemporary facts and future prospective.
Sharma AK; Taneja G; Kumar A; Sahu M; Sharma G; Kumar A; Sardana S; Deep A
Life Sci; 2019 Feb; 219():90-99. PubMed ID: 30639280
[TBL] [Abstract][Full Text] [Related]
20. Impact of the mode of protraction of basal insulin therapies on their pharmacokinetic and pharmacodynamic properties and resulting clinical outcomes.
Heise T; Mathieu C
Diabetes Obes Metab; 2017 Jan; 19(1):3-12. PubMed ID: 27593206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]